CEO SUMMARY: In this second phase of the whistleblower case against three cardiology testing labs and a sales consulting company, federal prosecutors are requesting a jury trial against the individuals named in the court documents filed August 7. Federal investigators alleged that executives at one lab began a fraud scheme in 1999 and then expanded that scheme to other labs over 15 years. The suit claims that the labs made improper payments to referring physicians.
Feds Show How Labs Took $500 Million from Medicare
In addition, private health insurers are estimated to have paid three labs another $500 to $700 million
- By R. Lewis Dark
- | From the Volume XXII NO. 13 - September 14, 2015 Issue
- Tags: anti kickback statute, blood testing, blood tests, clinical lab, clinical lab manager, clinical laboratories, Clinical Laboratory, clinical laboratory test, clinical laboratory tests, dark report, diagnostic lab, diagnostic laboratories, false claims act, genetic test, genetic testing, genetic tests, lab administrator, lab executive, lab industry, lab manager, lab managers, lab specimen, lab specimens, lab test, laboratories, laboratory test, laboratory tests, medical lab, Medical laboratory, medical laboratory test, medical laboratory tests, Medicare, pathologists, specialty lab, specialty laboratory, the dark report
